Top Markets
Coin of the day
BioHarvest Sciences Inc. Common Stock BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

BHST
Classement en actions #27032
BioHarvest Sciences Inc. functions as a biotechnology firm with operations... BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Prix de l'action
$2.06
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$35.61M
Changement (1 jour)
-2.61%
Changement (1 an)
-77.76%
Pays
CA
Échange BioHarvest Sciences Inc. Common Stock (BHST)
Bénéfices pour BioHarvest Sciences Inc. Common Stock (BHST)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de BioHarvest Sciences Inc. Common Stock, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour BioHarvest Sciences Inc. Common Stock de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$1.58B -
US
- -
CA
- -
CN
- -
US
$860.99M -
CN